You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-transfusion-dependent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia Trial in Canada, United Kingdom, United States (AG-348)

Active, not recruiting
Has Results
  • Thalassemia
  • Oakland, California
  • +3 more
Jan 26, 2023

Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

Active, not recruiting
Has Results
  • Thalassemia
  • Los Angeles, California
  • +16 more
Aug 16, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Beta Thalassemia Intermedia Trial in Worldwide (IONIS TMPRSS6-LRx)

Active, not recruiting
  • Beta Thalassemia Intermedia
  • Camperdown, New South Wales, Australia
  • +18 more
Sep 23, 2022

Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
Sep 6, 2021

Transfusion-dependent Anemia, Surgery, Anemia Trial in Germany (red blood cell transfusion trigger)

Recruiting
  • Transfusion-dependent Anemia
  • +2 more
  • red blood cell transfusion trigger
  • Aachen, Germany
  • +8 more
Mar 28, 2022

ß-thalassemia, Ineffective Erythropoiesis, Chronic Anemia Trial in Worldwide (PTG-300)

Completed
  • β-thalassemia
  • +2 more
  • Oakland, California
  • +32 more
Jul 13, 2021

Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)

Recruiting
  • Transfusion-dependent Thalassemia
  • Thalidomide Capsules
  • Placebo
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Oct 18, 2023

Transfusion-dependent Beta-thalassemia After Gene Therapy

Recruiting
  • Transfusion-dependent Beta-Thalassemia
  • Gene Therapy
  • Gene therapy
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 6, 2023

Beta Thalassemia Major Anemia Trial (SP-420)

Not yet recruiting
  • Beta Thalassemia Major Anemia
  • (no location specified)
Jan 20, 2023

Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)

Completed
  • Transfusion-dependent Beta-Thalassemia
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Blood Care Clinic
Nov 19, 2023

Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)

Recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Nanning, Guangxi, China
    PLA 923 Hospital
Mar 2, 2023

Transfusion-dependent Beta-Thalassemia Trial in Tianjin (KL003 cell injection Drug Product)

Not yet recruiting
  • Transfusion-dependent Beta-Thalassemia
  • KL003 cell injection Drug Product
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
May 8, 2023

Transfusion-dependent a-Thalassemia Trial (GMCN-508A Drug Product)

Not yet recruiting
  • Transfusion-dependent α-Thalassemia
  • GMCN-508A Drug Product
  • (no location specified)
Feb 24, 2023

Diamond Blackfan Anemia, Pure Red Cell Aplasia Trial in Boston, Manhasset (Trifluoperazine)

Terminated
Has Results
  • Diamond Blackfan Anemia
  • Pure Red Cell Aplasia
  • Boston, Massachusetts
  • +1 more
Nov 18, 2022

Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))

Recruiting
  • Transfusion Dependent Beta-Thalassemia
  • GMCN-508B (LentiRed)
  • Nanning, Guangxi, China
    The affiliated hospital of guangxi medical university
Feb 28, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

Physical Activity in Transfusion Dependent Myelodysplastic

Recruiting
  • Myelodysplastic Syndromes
  • Medical Device Usage and Evaluation
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 16, 2022

Thalassemia Major, Transfusion-dependent Anemia Trial in Guangzhou (Luspatercept Injectable Product)

Recruiting
  • Thalassemia Major
  • Transfusion-dependent Anemia
  • Luspatercept Injectable Product
  • Guangzhou, Guangdong, China
    The second affiliated hospital of Sun Yat-sen University
Jul 15, 2022

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
May 8, 2023

Prediction of Transfusion-Associated Complications

Completed
  • Transfusion-dependent Anemia
  • Transfusion of Allogeneic Blood
  • Linz, Upper Austria, Austria
    Kepler University Hospital
Aug 16, 2022

Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)

Completed
  • Thalassemia
  • Thalidomide and Hydroxyurea
  • Peshawar, Khyber Pakhtukhwa, Pakistan
    Blood Diseases Clinic
Mar 10, 2022

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Non-transfusion-dependent Thalassemia
  • +2 more
  • Düsseldorf, Germany
  • +19 more
Mar 18, 2022

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023